Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.2700
-0.0051 (-1.85%)
At close: Apr 16, 2026, 4:00 PM EDT
0.2772
+0.0072 (2.67%)
After-hours: Apr 16, 2026, 7:38 PM EDT

Sangamo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
112147217975241,094
Market Cap Growth
-24.12%-32.15%124.32%-81.52%-52.14%-50.63%
Enterprise Value
117.7151.43201.4349.29285.09761.92
Last Close Price
0.270.421.020.543.147.50
PE Ratio
--0.95-2.08-0.37-2.51-6.10
PS Ratio
2.833.723.760.554.719.89
PB Ratio
--10.329.531.171.782.92
P/TBV Ratio
-5.29-8.259.041.141.642.89
P/FCF Ratio
--1.51-3.22-0.39-2.15-4.27
P/OCF Ratio
--1.52-3.23-0.43-2.34-4.69
EV/Sales Ratio
2.983.833.480.282.566.88
EV/EBITDA Ratio
--1.29-2.02-0.18-1.48-4.35
EV/EBIT Ratio
--1.25-1.94-0.18-1.42-4.16
EV/FCF Ratio
--1.56-2.99-0.20-1.17-2.97
Debt / Equity Ratio
-1.76-1.761.150.400.130.12
Debt / EBITDA Ratio
-0.21-0.21-0.26-0.13-0.20-0.25
Debt / FCF Ratio
-0.26-0.26-0.39-0.14-0.16-0.17
Net Debt / Equity Ratio
-0.29-0.29-0.69-0.57-0.81-0.89
Net Debt / EBITDA Ratio
-0.04-0.040.160.181.241.90
Net Debt / FCF Ratio
-0.04-0.040.230.190.981.30
Asset Turnover
0.490.490.430.480.170.13
Quick Ratio
0.740.741.021.782.532.99
Current Ratio
0.840.841.131.982.693.12
Return on Equity (ROE)
-2891.84%-2891.84%-185.39%-136.47%-57.37%-40.86%
Return on Assets (ROA)
-149.56%-149.56%-77.76%-73.84%-31.41%-22.12%
Return on Invested Capital (ROIC)
-1290.85%-1290.85%-357.56%-205.49%-76.39%-66.97%
Return on Capital Employed (ROCE)
-331.67%-331.67%-119.91%-96.41%-38.53%-26.40%
Earnings Yield
-109.90%-104.76%-48.04%-272.41%-39.81%-16.40%
FCF Yield
-87.00%-66.07%-31.05%-254.18%-46.55%-23.44%
Buyback Yield / Dilution
-38.92%-38.92%-15.62%-13.02%-6.76%-7.53%
Total Shareholder Return
-38.92%-38.92%-15.62%-13.02%-6.76%-7.53%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q